Bid Publish Date
04-Aug-2026, 3:51 pm
Bid End Date
20-Aug-2026, 4:00 pm
Value
₹1,58,919
Location
Progress
Dg Armed Forces Medical Service invites bids for 10543, 11153, 11388, 11617, 11732, 12095, 13701, 10604 in WEST DELHI, DELHI. Quantity: 7665. Submission Deadline: 20-08-2026 16: 00: 00. Submit your proposal before the deadline.
Quantity
7665
Category
10543
Bid Type
Two Packet Bid
Bid Validity
180 (Days)
Bid Type
Service
Evaluation
Item wise evaluation
Inspection Required
No
RA Qualification Rule
50% Lowest Priced Technically Qualified Bidders
Tech Clarification Time
2 Days
EMD Required
No
MII Purchase Preference
Yes
MII Preference Band
L1+20%
MSE Purchase Preference
Yes
MSE Preference Band
L1+15%
MSE Exemption/Relaxation
Yes
Startup Exemption/Relaxation
Yes
Bid Splitting Applied
No
Past Performance
10 %
Arbitration Clause
No
Mediation Clause
No
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
10543 , 11153 , 11388 , 11617 , 11732 , 12095 , 13701 , 10604
Advisory Bank
State Bank of India
ePBG Percentage
3%
ePBG Duration (Months)
26
Max Delivery Days
30
Delivery Locations
1
Delivery Cities
SOUTH WEST DELHI
| Consignee | Address | City | State | Pincode | Quantity | Delivery Days | Additional Requirement |
|---|---|---|---|---|---|---|---|
| - | SOUTH WEST DELHI | SOUTH WEST DELHI | - | - | 690 | 30 | - |
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
10543
Lorazepam 2 mg slash ml comma 2 ml Inj
11153
Sodium Nitroprusside 50 mg Inj
11388
Betamethasone 0 dot 1 percentage + Salicylic Acid 3 percentage cream 20 gm tube
11617
Octreotide 0 dot 1mg slash ml Inj
11732
Dinoprostone Gel 0 dot 5mg(in 3gm slash 2 dot 5ml gel)slash Syringe
12095
Hyaluronidase 1500 IU Inj 2 ml
13701
Inj Nitroglycerine slash Glyceryltrinitrate 5 mg
10604
Ivermectin Tab 6mg
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | 10543 | Lorazepam 2 mg slash ml comma 2 ml Inj | 690 | amp or vial | oicreceipt | 30 | |
| 2 | 11153 | Sodium Nitroprusside 50 mg Inj | 210 | amp or vial | oicreceipt | 30 | |
| 3 | 11388 | Betamethasone 0 dot 1 percentage + Salicylic Acid 3 percentage cream 20 gm tube | 3,340 | no | oicreceipt | 30 | |
| 4 | 11617 | Octreotide 0 dot 1mg slash ml Inj | 210 | amp or vial | oicreceipt | 30 | |
| 5 | 11732 | Dinoprostone Gel 0 dot 5mg(in 3gm slash 2 dot 5ml gel)slash Syringe | 120 | no | oicreceipt | 30 | |
| 6 | 12095 | Hyaluronidase 1500 IU Inj 2 ml | 30 | vial | oicreceipt | 30 | |
| 7 | 13701 | Inj Nitroglycerine slash Glyceryltrinitrate 5 mg | 435 | amp | oicreceipt | 30 | |
| 8 | 10604 | Ivermectin Tab 6mg | 2,630 | no | oicreceipt | 30 |
Extended Deadline
17-Aug-2026, 10:30 am
Opening Date
17-Aug-2026, 11:00 am
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer